Proto Labs (PRLB) Tops Q1 EPS by 7c

Proto Labs (NYSE: PRLB) reported Q1 EPS of $0.30, $0.07 better than the analyst estimate of $0.23. Revenue for the quarter came in at $125.9 million versus the consensus estimate of $119.41 million.

For earnings history and earnings-related data on Proto Labs (PRLB) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
• INVO Fertility (IVF) Tops Q2 EPS by 105c